PYXS Pyxis Oncology beats Q4 2025 loss estimates but shares shed 235 percent amid weak investor reaction American Tower Corporation AMT Q1 2026 AFFO Revenue Beat Consensus Upside Catalysts Emerge Amid Sector Undervaluation Targa Resources TRGP PostDividend Hike and Permian Expansion Rally Catalysts Valuation and Risk Outlook The surprise hidden in Rimini RMNI last earnings report Q1 2026 Earnings Fall Short